Literature DB >> 34112942

Associations of hypertension burden on subsequent dementia: a population-based cohort study.

Hyunjean Jung1, Pil-Sung Yang2, Daehoon Kim1, Eunsun Jang1, Hee Tae Yu1, Tae-Hoon Kim1, Jung-Hoon Sung2, Hui-Nam Pak1, Moon-Hyoung Lee1, Gregory Y H Lip3, Boyoung Joung4.   

Abstract

In this nationwide cohort study, we assessed the effects of hypertension burden and blood pressure (BP) control on dementia in different age subgroups. From the Korean National Health Insurance Service-Health Screening cohort from January 1, 2005 to December 31, 2013, we enrolled 428,976 subjects aged 40-79 years without previous diagnosis of dementia or stroke. During a mean follow-up of 7.3 ± 1.5 years, 9435 (2.2%) were diagnosed with dementia. Per 10 mmHg increase in systolic BP (SBP), risk of dementia was increased by 22% (95% confidence interval [CI] 1.15-1.30) in subjects aged 40-59 years and 8% (95% CI 1.04-1.11) in subjects aged 60-69 years. No significant associations were observed in subjects aged ≥ 70 years. Among subjects aged 40-59 years, both vascular and Alzheimer's dementia risks were increased with increasing SBP. Increasing hypertension burden (proportion of days with increased BP) was associated with higher dementia risk (hazard ratio [HR] 1.09 per 10% increase, 95% CI 1.08-1.10). Among patients with baseline SBP ≥ 140 mmHg, optimal follow-up SBP (120-139 mmHg) was associated with decreased dementia risk (HR 0.69, 95% CI 0.50-0.95). Hypertension burden was associated with higher risks of dementia. Adequate BP control was associated with lower risk of dementia in individuals aged < 70 years.

Entities:  

Year:  2021        PMID: 34112942     DOI: 10.1038/s41598-021-91923-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  31 in total

Review 1.  The global prevalence of dementia: a systematic review and metaanalysis.

Authors:  Martin Prince; Renata Bryce; Emiliano Albanese; Anders Wimo; Wagner Ribeiro; Cleusa P Ferri
Journal:  Alzheimers Dement       Date:  2013-01       Impact factor: 21.566

2.  Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study.

Authors:  Yeong-Min Lim; Pil-Sung Yang; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung; Gregory Y H Lip
Journal:  Mayo Clin Proc       Date:  2019-02       Impact factor: 7.616

Review 3.  Is hypertension associated with an accelerated aging of the brain?

Authors:  Christophe Tzourio; Stéphane Laurent; Stéphanie Debette
Journal:  Hypertension       Date:  2014-02-24       Impact factor: 10.190

Review 4.  Defeating Alzheimer's disease and other dementias: a priority for European science and society.

Authors:  Bengt Winblad; Philippe Amouyel; Sandrine Andrieu; Clive Ballard; Carol Brayne; Henry Brodaty; Angel Cedazo-Minguez; Bruno Dubois; David Edvardsson; Howard Feldman; Laura Fratiglioni; Giovanni B Frisoni; Serge Gauthier; Jean Georges; Caroline Graff; Khalid Iqbal; Frank Jessen; Gunilla Johansson; Linus Jönsson; Miia Kivipelto; Martin Knapp; Francesca Mangialasche; René Melis; Agneta Nordberg; Marcel Olde Rikkert; Chengxuan Qiu; Thomas P Sakmar; Philip Scheltens; Lon S Schneider; Reisa Sperling; Lars O Tjernberg; Gunhild Waldemar; Anders Wimo; Henrik Zetterberg
Journal:  Lancet Neurol       Date:  2016-04       Impact factor: 44.182

Review 5.  Clinical Trials of Blood Pressure Lowering and Antihypertensive Medication: Is Cognitive Measurement State-of-the-Art?

Authors:  Merrill F Elias; Rachael V Torres; Adam Davey
Journal:  Am J Hypertens       Date:  2018-05-07       Impact factor: 2.689

Review 6.  Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.

Authors:  Laure Rouch; Philippe Cestac; Olivier Hanon; Charlène Cool; Catherine Helmer; Béatrice Bouhanick; Bernard Chamontin; Jean-Franҫois Dartigues; Bruno Vellas; Sandrine Andrieu
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

Review 7.  The age-dependent relation of blood pressure to cognitive function and dementia.

Authors:  Chengxuan Qiu; Bengt Winblad; Laura Fratiglioni
Journal:  Lancet Neurol       Date:  2005-08       Impact factor: 44.182

8.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Nicholas M Pajewski; Alexander P Auchus; R Nick Bryan; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Meng-Kang Hsieh; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Ilya M Nasrallah; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright
Journal:  JAMA       Date:  2019-02-12       Impact factor: 56.272

9.  Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea.

Authors:  Sean S Lee; Kyoung Ae Kong; Daehoon Kim; Yeong-Min Lim; Pil-Sung Yang; Jeong-Eun Yi; Minsuk Kim; Kihwan Kwon; Wook Bum Pyun; Boyoung Joung; Junbeom Park
Journal:  Eur Heart J       Date:  2017-09-07       Impact factor: 29.983

Review 10.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

View more
  1 in total

1.  Mortality rate of high cardiovascular risk patients with mild cognitive impairment.

Authors:  Teodora Yaneva-Sirakova; Latchezar Traykov
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.